Section Arrow
CV.NASDAQ
- CapsoVision
Quotes are at least 15-min delayed:2025/08/26 09:07 EDT
Pre Market
Last
 3.91
-0.08 (-2.01%)
Bid
3.91
Ask
3.98
High 3.97 
Low 3.91 
Volume 100 
Regular Hours
Last
 --
-- (--)
Day High 
-- 
Prev. Close
3.99 
1-M High
4.6 
Volume 
-- 
Bid
3.91
Ask
3.98
Day Low
-- 
Open
-- 
1-M Low
3.81 
Market Cap 
186.63M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 3.98 
20-SMA 4.05 
50-SMA -- 
52-W High 5.72 
52-W Low 3.49 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.44/-0.22
Enterprise Value
187.52M
Balance Sheet
Book Value Per Share
-2.97
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
11.76M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ZIMVZimVie----0.000%-- 
Pre Market 18.96 0 0.00%
ZBHZimmer Biomet Holdings----0.000%-- 
Pre Market 107.9097 +0.5897 +0.55%
XYLOXylo Technologies Ltd----0.000%-- 
Pre Market -- -- --
XTNTXtant Medical Holdings----0.000%-- 
Pre Market -- -- --
XAIRBeyond Air Inc----0.000%-- 
Pre Market 2.21 -0.07 -3.07%
Quotes are at least 15-min delayed:2025/08/26 09:07 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
CapsoVision Inc is a commercial-stage medical technology enterprise, innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. Internal GI imaging facilitates earlier detection of colorectal cancer and other diseases, enabling more timely and effective treatment regimens for patients. The Company's core technology platform is an orally ingestable capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. The Company's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D directed at the large intestines.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.